A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
NCT01800071
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Cancer
Epstein Barr Virus Infections
Interventions
DRUG:
MVA-EBNA1/LMP2 vaccine
Sponsor
Cancer Research UK